Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6314)
All Articles published online
|
Publishing Process of This Article
|
Apr 24, 2024 (publication date) through Dec 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Lucke-Wold B, Rangwala BS, Shafique MA, Siddiq MA, Mustafa MS, Danish F, Nasrullah RMU, Zainab N, Haseeb A. Focus on current and emerging treatment options for glioma: A comprehensive review. World J Clin Oncol 2024; 15(4): 482-495 [PMID: 38689623 DOI: 10.5306/wjco.v15.i4.482] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Lucke-Wold B, Rangwala BS, Shafique MA, Siddiq MA, Mustafa MS, Danish F, Nasrullah RMU, Zainab N, Haseeb A. Focus on current and emerging treatment options for glioma: A comprehensive review. World J Clin Oncol 2024; 15(4): 482-495 [PMID: 38689623 DOI: 10.5306/wjco.v15.i4.482] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i4/482.htm |
| Number | Citing Articles |
| 1 |
Zahra Bazi, Mahdi Aalikhani. Bioinformatics Analysis of Glioma Neoantigens: Identifying Novel Targets for Immunotherapy. South Medical Journal 2025; 28(1): 473 doi: 10.61882/ismj.28.1.473
|
| 2 |
Yujing Wen, Wenhao Zhou, Zhenzhen Zhao, Didi Ma, Jian Mao, Yingjie Cai, Fugui Liu, Juan Zhou, Kun Lv, Wenchao Gu, Lan Jiang. Annexin A’s Life in Pan-Cancer: Especially in Glioma Immune Cells. NeuroMolecular Medicine 2025; 27(1) doi: 10.1007/s12017-024-08827-9
|
| 3 |
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher. Fighting Cancer with Photodynamic Therapy and Nanotechnologies: Current Challenges and Future Directions. International Journal of Molecular Sciences 2025; 26(7): 2969 doi: 10.3390/ijms26072969
|
| 4 |
Xixi Wei, Yang Wang, Wanlong Zhao, Wenqian Yang, Jiaping Tang, Baosheng Zhao, Yuzhen Liu. Knockdown of ACC1 promotes migration and invasion of U251 glioma cells by epigenetically suppressing SDH. International Journal of Oncology 2025; 67(3): 1 doi: 10.3892/ijo.2025.5779
|
| 5 |
Simin Wang, Jiyong Wu, Wenfei Zhang, Jing Nie. Effects and safety of TMZ plus RT combined with other drugs in the treatment of glioblastoma: a network meta-analysis. Future Oncology 2025; 21(17): 2237 doi: 10.1080/14796694.2025.2516408
|
| 6 |
Dingwen Xu, Liang He, Xu Zhao, Zhe Yang. Bibliometric evaluation of research trends and hotspots concerning the interaction between immune checkpoint inhibitors and glioma. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-04013-w
|
| 7 |
Yuhao Shi, Sravya Koduri, Jonathan T. Yang, Brandon S. Imber. Development of investigational radiotherapeutics for the diagnosis and treatment of glioma. Expert Opinion on Investigational Drugs 2025; 34(10): 745 doi: 10.1080/13543784.2025.2564966
|
| 8 |
Xuan-Hao Pan, Bei-Wu Lan, Nan Wang, Jing Su, Yu-Fei Gao. Metabolic and epigenetic dysregulation in IDH1/2-mutant gliomas: A microglial-mediated mechanism of blood-brain barrier disruption. International Immunopharmacology 2026; 169: 115970 doi: 10.1016/j.intimp.2025.115970
|
| 9 |
Lei Li, Jiang-hua Yang, Xin-meng Fa, Ming-song Liu, Qi-lin Wang, Tong-fei Zeng, Rui-zhe Chen, Jun Ou, Xue-wei Xia. Preliminary investigation of nitric oxide release from upconverted nanoparticles excited at 808 nm near-infrared for brain tumors. Heliyon 2024; 10(13): e33576 doi: 10.1016/j.heliyon.2024.e33576
|
| 10 |
Umair Ali Khan Saddozai, Zhendong Lu, Shuangshuang Dong, Muhammad Babar Khawar, Zhehao Fan, Liangliang Cai, Xiaohui Guo, Muhammad Usman Akbar, Saadullah Khattak, Haibo Sun, Yajun Wang. Prognostic value of metal-based ferroptosis and cuproptosis genes and score in lower grade gliomas. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1608077
|
| 11 |
Zongye Zhang, Zhi Sha, Hao Wang, Yusheng Chen, Zhendong Liu, Xingbo Cheng, Sujie Gu, Yanzheng Gao. PSMC3IP as a prognostic biomarker and immunomodulatory regulator in low-grade glioma: insights from multi-omics and methylation analysis. Neurological Research 2025; : 1 doi: 10.1080/01616412.2025.2528159
|
| 12 |
Yan Li, Fanjing Jiang, Suhua Zhu, Hongwei Jia, Changwei Li. STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1419072
|
| 13 |
George B. H. Green, Alexis N. Cox-Holmes, Anna Claire E. Potier, Gillian H. Marlow, Braden C. McFarland. Modulation of the Immune Environment in Glioblastoma by the Gut Microbiota. Biomedicines 2024; 12(11): 2429 doi: 10.3390/biomedicines12112429
|
| 14 |
Muhammad Khan, Xiuting Huang, Xiaoxin Ye, Donghui Zhang, Baiyao Wang, Anan Xu, Rong Li, Anbang Ren, Chengcong Chen, Jingjing Song, Rong Zheng, Yawei Yuan, Jie Lin. Necroptosis-based glioblastoma prognostic subtypes: implications for TME remodeling and therapy response. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2405079
|
| 15 |
Ivana Karmelić, Mia Jurilj Sajko, Tomislav Sajko, Krešimir Rotim, Dragana Fabris. The role of sphingolipid rheostat in the adult-type diffuse glioma pathogenesis. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1466141
|